Phase 1 Trial of Chlorogenic Acid in Patients With Advanced Cancer

Chinese Academy of Medical Sciences & Peking Union Medical College

Status and phase: Terminated; Phase 1

Conditions: Advanced Cancer

Treatments: Drug: chlorogenic acid

Study type: Interventional

Funder types: Other; Industry

Identifiers

NCT02136342

LYS-I-01

Details and patient eligibility

About

The purpose of the study is to explore if chlorogenic acid is safe in patients with cancer.

Sex: All

Ages: 18 to 65 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• advanced cancer with no effective treatment
• Karnofsky performance status no less than 70
• adequated organ function
• informed consent

Exclusion criteria

• allergic to chlorogenic acid
• persistent toxicities from previous treatment (no less than grade 2)

Trial design

Primary purpose: Treatment

Allocation: N/A

Interventional model: Single Group Assignment

Masking: None (Open label)

---

0 participants in 1 patient group

chlorogenic acid

Experimental group

Treatment:

Drug: chlorogenic acid